StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.2
  1. Startseite
  2. /Verbindung

4-Methyl-1H-pyrazol

4-Methylpyrazole

HCID 3406
Neue Reaktion
Drucken

Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen

GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
7554-65-6
Standard-SMILES
Cc1cn[nH]c1
InChIKey
RIKMMFOAQPJVMX-UHFFFAOYSA-N
Summenformel
C4H6N2
Durchschnittliche Molmasse
82,1 g/mol
Monoisotopische Masse
82,0530982

Überblick

Fomepizole is a member of the class of pyrazoles that is 1H-pyrazole substituted by a methyl group at position 4. It has a role as an antidote, a protective agent and an EC 1.1.1.1 (alcohol dehydrogenase) inhibitor. It derives from a hydride of a 1H-pyrazole.

Namen und Bezeichner

Bevorzugter Name
4-Methylpyrazole
IUPAC
4-methyl-1H-pyrazole
Lokaler Name
4-Methyl-1H-pyrazol
Englischer Name
4-Methylpyrazole
Summenformel
C4H6N2
Molmasse
82.1

Namen und Synonyme

4-Methylpyrazolefomepizole7554-65-61H-Pyrazole, 4-methyl-Fomepizol4-MethylpyrazolFomepizolumCHEBI:514183LCM6L2BYNSC-760365DTXSID30406494 Methylpyrazole
Weitere Namen anzeigen
Antizol-VetAKOS B014452Antizol (TN)4-Fomepizole4-methyl-pyrazol
4 Methylpyrazole MonohydrochlorideRefChem:58530DTXCID1020649V03AB34231-445-04-Methyl-1H-pyrazoleAntizolFomepizol [INN-Spanish]

Datenbank-Bezeichner

CAS
7554-65-6
PubChem CID
3406
DTXSID
DTXSID3040649
ChEMBL
CHEMBL1308
ChEBI
CHEBI:5141
UNII
83LCM6L2BY
EC Number
231-445-0
Nikkaji
J35.396E

Eigenschaften

Berechnete StruktureigenschaftenWird ergänzt

XLogP
1,4
Polarare Oberfläche (TPSA)
28,7 Ų
H-Brücken-Donoren
1
H-Brücken-Akzeptoren
1
Frei drehbare Bindungen
0
Schwere Atome
6
Formalladung
0
Komplexität
44,8

Experimentelle und physikochemische Eigenschaften

Drugs · 2 Einträge

Pharmaceutical

Pharmaceuticals -> Listed in ZINC15

SpringerMaterials PropertiesOptical coefficient
LogP0.9
Solubility5.59e+02 g/L
Human Drugs · 3 Einträge

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Antidotes and other substances used in poisonings > Specific

Animal DrugsFDA approved animal drugs -> Active ingredient
Melting Point25 °C
Physical DescriptionSolid

Physikochemische Eigenschaften

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

GHS-Klassifizierung

GHS Classification · 4 Einträge

Danger

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

P260, P261, P264, P264+P265, P270, P271, P280, P301+P317, P301+P330+P331, P302+P352, P302+P361+P354, P304+P340, P305+P351+P338, P305+P354+P338, P316, P317, P319, P321, P330, P332+P317, P337+P317, P362+P364, P363, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 154 reports by companies from 11 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Gefahrenhinweise

Regulatory InformationREACH registered substance: 4-methylpyrazole (EC: 231-445-0)
Hazard Classes and CategoriesAcute Tox. 4 (100%)

Toxikologische Informationen

Drug Induced Liver Injury · 6 Einträge

Drug Induced Liver Injury Rank (DILIrank 2.0)

Fomepizole

Ambiguous-DILI-concern

3

Warnings & precautions

DOI:10.1016/j.drudis.2016.02.015

Sicherheitsdaten

F
10-23
wgk
3
ridadr
2810
hs_code
29331990
RTECS-Nr.
UQ7350000
risk_code
22-36/37/38

Chemie und Industrie

Pharmakologische Informationen

ATC Code · 3 Einträge

V - Various

QV - Various

V03AB34

Pharmacodynamics · 1 Eintrag

Fomepizole is a competitive inhibitor of alcohol dehydrogenase, the enzyme that catalyzes the initial steps in the metabolism of ethylene glycol and methanol to their toxic metabolites. Ethylene glycol is first metabolized to glycoaldehyde which then undergoes further oxidation to glycolate, glyoxylate, and oxalate. Glycolate and oxalate are primarily responsible for metabolic acidosis and renal damage seen in ethylene glycol toxicity. {01}{03} Methanol is first metabolized to formaldehyde and then undergoes subsequent oxidation via formaldehyde dehydrogenase to become formic acid. It is formic acid that is primarily responsible for the metabolic acidosis and visual disturbances that are associated with methanol poisoning.

Mechanism of Action · 1 Eintrag

Antizol (fomepizole) is a competitive inhibitor of alcohol dehydrogenase. Alcohol dehydrogenase catalyzes the oxidation of ethanol to acetaldehyde. Alcohol dehydrogenase also catalyzes the initial steps in the metabolism of ethylene glycol and methanol to their toxic metabolites.

Biological Half-LifeThe plasma half-life of Antizol varies with dose, even in patients with normal renal function, and has not been calculated.
Metabolism/Metabolites · 1 Eintrag

Primarily hepatic. the primary metabolite is 4-carboxypyrazole (approximately 80 to 85% of an administered dose). Minor metabolites include 4-hydroxymethylpyrazole and the N -glucuronide conjugates of 4-carboxypyrazole and 4-hydroxymethylpyrazole.

FDA Pharmacological Classification · 6 Einträge

83LCM6L2BY

FOMEPIZOLE

Established Pharmacologic Class [EPC] - Antidote

Fomepizole is an Antidote.

FOMEPIZOLE

Antidote [EPC]

MeSH Pharmacological Classification

Zugehörige Reaktionen

110
Reaktionsaufzeichnung erstellen
Reaktionsgleichung von HRID 32766
HRID 32766als Edukt
Reaktionsgleichung von HRID 32767
HRID 32767als Edukt
Reaktionsgleichung von HRID 61031
HRID 61031als Edukt
Reaktionsgleichung von HRID 72269
HRID 72269als Edukt
Reaktionsgleichung von HRID 114768
HRID 114768als Edukt
Reaktionsgleichung von HRID 166309
HRID 166309als Edukt
Reaktionsgleichung von HRID 187612
HRID 187612als Edukt
Reaktionsgleichung von HRID 191495
HRID 191495als Edukt
ZurückSeite 1 von 14

Notizen zur Verbindung

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
Schmelzpunkt
13 °C · 13°C
Siedepunkt
99 · 99-100 °C6 mm Hg(lit.)
Dichte
0.993 g/mL · 0.993 g/mL at 25 °C(lit.)
Dampfdruck
7.136 · 7.136-87.85Pa at 20-50℃
Brechungsindex
20 · n20/D 1.495(lit.)
Flammpunkt
205 °F · 205 °F
storage temp.
Keep in dark place,Sealed in dry,Room Temperature
Löslichkeit
soluble
pka
14.95 · 14.95±0.50(Predicted)
Aggregatzustand
Liquid After Melting
Farbe
Clear colorless to yellow
Wichte
0.993 · 0.993
Wasserlöslichkeit
soluble
Merck
14 · 14,4226
BRN
105204 · 105204
InChI
1S/C4H6N2/c1-4-2-5-6-3-4/h2-3H,1H3,(H,5,6)
InChIKey
RIKMMFOAQPJVMX-UHFFFAOYSA-N
SMILES
Cc1cn[nH]c1
LogP
1.097 · 1.097 (est)
CAS Datenbank
7554 · 7554-65-6(CAS DataBase Reference)
NIST chemische Informationen
4 · 4-methylpyrazole(7554-65-6)
Toxizität
LD50 (7 days) in mice, rats (mmol/kg): 3.8, 3.8 i.v.; 7.8, 6.5 orally (Magnusson)
hazard_code
Xn
safety_code
26-36-24/25
hazard_class
6.1(b)
packing_group
III
Speicherklasse
10 - Combustible liquids
Hazard Classifications
Acute Tox. 4 OralEye Irrit. 2Skin Irrit. 2STOT SE 3
· 2 Einträge

Agents counteracting or neutralizing the action of POISONS.

Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction.

Absorption, Distribution and Excretion · 3 Einträge

Rapid and complete

In healthy volunteers, only 1-3.5% of the administered dose of Antizol® (7-20 mg/kg oral and IV) was excreted unchanged in the urine, indicating that metabolism is the major route of elimination. In humans, the primary metabolite of Antizol® is 4-carboxypyrazole (approximately 80-85% of administered dose), which is excreted in the urine. The metabolites of Antizol® are excreted renally.

0.6 to 1.02 L/kg

Cellular LocationsCytoplasm
Anwendungen · 2 Einträge

BeschreibungFomepizole is the first drug indicated as an antidote for ethylene glycol poisoning (it has also shown promise as a treatment for methanol poisoning). Fomepizole is 4-methyl-1H-pyrazole active as a synthetic alcohol dehydrogenase inhibitor, blocking the formation of toxic ethylene glycol metabolites which are responsible for a severe metabolic acidosis and renal failure. In limited human studies, it reversed the toxicity of potentially lethal doses of ethylene glycol. The main urinary metabolite has been reported to be 4-carboxypyrazole by oxidation of the methyl group. Compared with the current treatment (ethanol), the duration of action is longer and the safety is improved, with no toxic effects reported.

VerwendenFomepizole (4-Methylpyrazole) can be used as: A reactant to prepare 4-methyl-1-phenyl-1H-pyrazole by reacting with bromobenzene via N-arylation using a copper catalyst. A starting material for the synthesis of 4-methyl-3(5)-nitropyrazole by nitration. A ligand in the preparation of gallium(III) complex of 4-methylpyrazole as potential antitumor and antiviral agent.

Vor- und nachgelagerte Produkte

Vorgelagerte Rohstoffe

SchwefelsureIsobutyraldehydNatriumiodidHydrazine hydrate1,1,3,3-Tetraethoxy-2-methylpropan2-Methylallylacetat4-Methylpyrazole-5-carboxylic acid3-Amino-2-methylacrylaldehydeformamideHydrazinium(2+)-sulfat

Nachgelagerte Produkte

1H-Pyrazole,4-methyl-1-nitro-(9CI)Antihistamine-1

Ergänzende Hinweise

DefinitionChEBI: A member of the class of pyrazoles that is 1H-pyrazole substituted by a methyl group at position 4.